// App-Quantinova.ai

P3-01-20 : Werner syndrome protein (WRN) is a negative regulator of cellular migration of breast cancer cells and is associated with the clinical outcome in breast cancer

Researchers

Presenter

  • Shuo Cai

Principal Investigators

  • Lin Ye

  • Zhe Zhao

  • Jane Lane

  • Tracey A. Martin

  • Eleri Davies

  • Robert E. Mansel

  • Wen G. Jiang

Medical Centers

  • School of Medicine, Cardiff University, Cardiff, United Kingdom

  • School of Medicine & School of Engineering, Cardiff University, Cardiff, United Kingdom

  • Wales Breast Cancer, University Llandough Hospital, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Werner syndrome

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved